Serbian newspapers are reporting about RocketVax’s development of an effective and safe COVID-19 vaccine
The COVID-19 pandemic has led to a dramatic loss of human life worldwide and presents an unprecedented challenge to public health, food systems, and the world of work. The coronavirus is currently affecting 218 countries and territories around the world.
Therefore, the rapid development of an effective and safe vaccine against SARS-CoV-2 is a top priority for RocketVax. As a Basel-based subsidiary, RocketVax was founded to utilize innovative Swiss technologies and expertise to achieve this goal.
Serbia is one of the countries that have been badly affected by pandemics. Therefore, Serbian journalists are keeping up with information and achievements regarding COVID-19 vaccines constantly, in order to inform the public about every possible solution. They are particularly curious about the RocketVax COVID-19 vaccine development since the CEO of the company, Dr. Vladimir Cmiljanovic, was born and raised in Serbia.
